Exosomes for acute ischemic stroke treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether exosomes from human stem cells can help people recover after a stroke in the front part of the brain. You must start treatment within one week of the stroke, have a certain level of disability, and be generally healthy otherwise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a stroke in the front part of the brain, confirmed by MRI or CT scan.
- You can start the study treatment within 7 days after your stroke symptoms began.
- Your stroke symptoms are moderate to moderately severe (NIHSS score 6–20).
- You were able to do most daily activities on your own before this stroke.
- You are not pregnant, and you agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This clinical trial is testing a treatment made from stem cell exosomes — tiny particles that help cells communicate — given through an IV to people who have had a recent ischemic stroke caused by a blood clot. The study aims to see if it's safe and can help recovery when given within the first few days after a stroke.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests a new treatment called NouvSoma001 for people who have had an ischemic stroke within the last week. It aims to see if the treatment is safe and helps improve muscle strength and overall recovery.
This trial tests whether umbilical cord stem cells given within a month after a stroke can help patients recover. It is for people with a moderate to moderately severe stroke affecting the front part of the brain.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
Hear when a new Ischemic Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.